Author: Yan Jun-Wei Wang Yu-Jie Peng Wen-Jia Tao Jin-Hui Wan Ya-Nan Li Bao-Zhu Mei Bin Chen Bing Yao Hua Yang Guo-Jun Li Xiang-Pei Ye Dong-Qing Wang Jing
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.18, Iss.1, 2014-01, pp. : 29-41
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
MicroRNA-21 with therapeutic potential in autoimmune diseases
By Xu Wang-Dong
Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 6, 2013-09 ,pp. :
IL-19 as a Potential Therapeutic in Autoimmune and Inflammatory Diseases
Current Pharmaceutical Design, Vol. 17, Iss. 34, 2011-11 ,pp. :
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 2, 2014-06 ,pp. :
Modern Therapeutic Strategies for Autoimmune Diseases
Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. :